Implementation Roadmap
Translating complex legal frameworks into a chronological execution plan. Aligning capital deployment alongside regulatory timelines.
Entry Planning Phase
Months -2 to 0: Preliminary mapping of business goals to KBLI categories. Finalizing founder shareholding percentages (ensuring they meet the 1.125B IDR Investor KITAS minimum) and selecting initial directors.
Structural Planning Phase
Defining the immediate PT PMA capital timeline versus long-term capitalization strategy. Engaging local tax consultants to forecast corporate tax obligations and capital extraction models.
24-Month Deployment Gantt Chart
Timeline visualization mapping regulatory milestones against operational execution.
Hover over or tap a timeline phase to view operational milestones.
Incorporation Phase
The SK Kemenkumham Milestone
Zoning Validation Phase
Months 1-3 post-incorporation: Utilizing the active PT PMA to formalize due diligence on target properties or securing a mid-term commercial lease in a verified Pariwisata (tourism) or Perdagangan (commercial) zone.
Immigration Phase
Bank Account Prioritization
Operational Activation Phase
Months 4-8: Progressing standard OSS licenses (NIB) to verified, active status by submitting Environmental Documentation (SPPL), Building Approvals (PBG), and passing local inspection reviews.
Compliance Reporting Phase
Establishing quarterly routines. Indonesia requires strict, periodic LKPM (Investment Activity) filings. Missing these flags the entity in the BKPM system, freezing OSS access, and stalling future visa renewals.
Stabilization Phase
Months 9-18: Navigating the first fiscal year-end close. Ensuring all personnel (local + foreign) are correctly logged into BPJS Health and BPJS Manpower systems, neutralizing labor compliance vulnerabilities.
Expansion Review Phase
- Reviewing the 10 Billion IDR capital threshold realization status.
- Analyzing current operational scope vs KBLI boundaries.
- Beginning preparations for Investor KITAS renewals or transitioning to 5-year permanence pathways.